Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 51

Results For "Biologics"

567 News Found

Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis
Biotech | December 24, 2021

Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis

Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000


Lecanemab granted Fast Track designation by the U.S. FDA
Biotech | December 24, 2021

Lecanemab granted Fast Track designation by the U.S. FDA

Alzheimer's disease is a serious, progressive and devastating disease with few treatment options


CanSinoBio’s Convidecia vaccine largely effective against Covid-19 in phase III trial
News | December 24, 2021

CanSinoBio’s Convidecia vaccine largely effective against Covid-19 in phase III trial

The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia


Piramal Pharma takes a minority stake in Yapan Bio
Biotech | December 22, 2021

Piramal Pharma takes a minority stake in Yapan Bio

The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space


Astra Zeneca’s antibody combination to prevent Covid-19 neutralises Omicron variant
News | December 17, 2021

Astra Zeneca’s antibody combination to prevent Covid-19 neutralises Omicron variant

The study was performed independently by investigators at the US Food and Drug Administration (FDA), Center for Biologics Evaluation and Research


Aragen Life Sciences acquires Intox
Biotech | December 15, 2021

Aragen Life Sciences acquires Intox

Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune


Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement
Biotech | December 14, 2021

Glenmark subsidiary, Ichnos Sciences and Almirall enter exclusive licencing agreement

Ichnos will receive an upfront payment of Euro 20.8 million as well as additional development and commercial milestone payments and tiered royalties based upon future global sales


Hilleman Laboratories invests US $ 58 mn to establish vaccine hub in Singapore
Biotech | December 07, 2021

Hilleman Laboratories invests US $ 58 mn to establish vaccine hub in Singapore

The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.


Lupin and Biomm  tie-up for pegfilgrastim in Brazil
News | December 05, 2021

Lupin and Biomm tie-up for pegfilgrastim in Brazil

Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar


Eris signs JV with MJ Biopharm to supply insulin in India
News | December 05, 2021

Eris signs JV with MJ Biopharm to supply insulin in India

MJ will be paid a one-time lumpsum licence fee of Rs 15 crore